Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BDT

Apolipoprotein B 100 bound to LDL receptor and legobody

This is a non-PDB format compatible entry.
Summary for 9BDT
Entry DOI10.2210/pdb9bdt/pdb
EMDB information44469
DescriptorApolipoprotein B-100, Legobody 8D3 Fab Heavy Chain, Legobody 8D3 Fab Light Chain, ... (9 entities in total)
Functional Keywordsldl, apob100, ldl receptor, lipid transport
Biological sourceMus musculus
More
Total number of polymer chains7
Total formula weight831615.50
Authors
Dearborn, A.D.,Reimund, M.,Graziano, G.,Lei, H.,Kumar, A.,Neufeld, E.B.,Remaley, A.T.,Marcotrigiano, J. (deposition date: 2024-04-12, release date: 2024-12-25, Last modification date: 2025-03-05)
Primary citationReimund, M.,Dearborn, A.D.,Graziano, G.,Lei, H.,Ciancone, A.M.,Kumar, A.,Holewinski, R.,Neufeld, E.B.,O'Reilly, F.J.,Remaley, A.T.,Marcotrigiano, J.
Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor.
Nature, 638:829-835, 2025
Cited by
PubMed Abstract: Apolipoprotein B100 (apoB100) is a structural component of low-density lipoprotein (LDL) and a ligand for the LDL receptor (LDLR). Mutations in apoB100 or in LDLR cause familial hypercholesterolaemia, an autosomal dominant disease that is characterized by a marked increase in LDL cholesterol (LDL-C) and a higher risk of cardiovascular disease. The structure of apoB100 on LDL and its interaction with LDLR are poorly understood. Here we present the cryo-electron microscopy structures of apoB100 on LDL bound to the LDLR and a nanobody complex, which can form a C-symmetric, higher-order complex. Using local refinement, we determined high-resolution structures of the interfaces between apoB100 and LDLR. One binding interface is formed between several small-ligand-binding modules of LDLR and a series of basic patches that are scattered along a β-belt formed by apoB100, encircling LDL. The other binding interface is formed between the β-propeller domain of LDLR and the N-terminal domain of apoB100. Our results reveal how both interfaces are involved in LDL dimer formation, and how LDLR cycles between LDL- and self-bound conformations. In addition, known mutations in either apoB100 or LDLR, associated with high levels of LDL-C, are located at the LDL-LDLR interface.
PubMed: 39663455
DOI: 10.1038/s41586-024-08223-0
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (5.4 Å)
Structure validation

235458

PDB entries from 2025-04-30

PDB statisticsPDBj update infoContact PDBjnumon